APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rare Genetic Disease Diagnosis Solution

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Rare Genetic Disease Diagnosis Solution Market Analysis and Forecast 2026-2032

11 April 2026216 pages

Choose your research edition.

Industry ResearchRare Genetic Disease Diagnosis Solution Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Rare Genetic Disease Diagnosis Solution Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Rare Genetic Disease Diagnosis Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rare Genetic Disease Diagnosis Solution Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Rare Genetic Disease Diagnosis Solution Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Rare Genetic Disease Diagnosis Solution market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Rare Genetic Disease Diagnosis Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Rare Genetic Disease Diagnosis Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Rare Genetic Disease Diagnosis Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Rare Genetic Disease Diagnosis Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Rare Genetic Disease Diagnosis Solution include Retrophin, 3billion, 23andMe, Ancestry, GeneDx, Ambry Genetics, QIAGEN, Illumina and PerkinElmer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Rare Genetic Disease Diagnosis Solution, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rare Genetic Disease Diagnosis Solution, also provides the revenue of main regions and countries. Of the upcoming market potential for Rare Genetic Disease Diagnosis Solution, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rare Genetic Disease Diagnosis Solution revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rare Genetic Disease Diagnosis Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Rare Genetic Disease Diagnosis Solution revenue, projected growth trends, production technology, application and end-user industry.

Rare Genetic Disease Diagnosis Solution Segment by Company

Retrophin

3billion

23andMe

Ancestry

GeneDx

Ambry Genetics

QIAGEN

Illumina

PerkinElmer

Strand Life Sciences

Rare Genetic Disease Diagnosis Solution Segment by Type

Genetic Testing

Biochemical Testing

Imaging and Diagnostic Procedures

Others

Rare Genetic Disease Diagnosis Solution Segment by Application

Clinical Genetics and Pediatric Clinic

Newborn Screening Program

Research and Development

Others

Rare Genetic Disease Diagnosis Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rare Genetic Disease Diagnosis Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rare Genetic Disease Diagnosis Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rare Genetic Disease Diagnosis Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Rare Genetic Disease Diagnosis Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Rare Genetic Disease Diagnosis Solution company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rare Genetic Disease Diagnosis Solution revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Genetic Testing Major Player Table 3. Biochemical Testing Major Player Table 4. Imaging and Diagnostic Procedures Major Player Table 5. Others Major Player Table 6. Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Clinical Genetics and Pediatric Clinic Major Player Table 8. Newborn Screening Program Major Player Table 9. Research and Development Major Player Table 10. Others Major Player Table 11. Rare Genetic Disease Diagnosis Solution Industry Trends Table 12. Rare Genetic Disease Diagnosis Solution Industry Drivers Table 13. Rare Genetic Disease Diagnosis Solution Industry Opportunities and Challenges Table 14. Rare Genetic Disease Diagnosis Solution Industry Restraints Table 15. Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Rare Genetic Disease Diagnosis Solution Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Rare Genetic Disease Diagnosis Solution Market Share by Region (2021-2026) Table 18. Global Rare Genetic Disease Diagnosis Solution Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Rare Genetic Disease Diagnosis Solution Market Share by Region (2027-2032) Table 20. Global Rare Genetic Disease Diagnosis Solution Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Players (2021-2026) Table 22. Global Rare Genetic Disease Diagnosis Solution Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Rare Genetic Disease Diagnosis Solution Key Players Headquarters & Area Served Table 24. Global Rare Genetic Disease Diagnosis Solution Players, Product Type & Application Table 25. Global Rare Genetic Disease Diagnosis Solution Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Rare Genetic Disease Diagnosis Solution by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Rare Genetic Disease Diagnosis Solution Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Rare Genetic Disease Diagnosis Solution Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Type (2021-2026) Table 32. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Type (2027-2032) Table 33. Global Rare Genetic Disease Diagnosis Solution Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Rare Genetic Disease Diagnosis Solution Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Application (2021-2026) Table 37. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Application (2027-2032) Table 38. Retrophin Company Information Table 39. Retrophin Business Overview Table 40. Retrophin Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Retrophin Rare Genetic Disease Diagnosis Solution Product Portfolio Table 42. Retrophin Recent Development Table 43. 3billion Company Information Table 44. 3billion Business Overview Table 45. 3billion Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. 3billion Rare Genetic Disease Diagnosis Solution Product Portfolio Table 47. 3billion Recent Development Table 48. 23andMe Company Information Table 49. 23andMe Business Overview Table 50. 23andMe Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. 23andMe Rare Genetic Disease Diagnosis Solution Product Portfolio Table 52. 23andMe Recent Development Table 53. Ancestry Company Information Table 54. Ancestry Business Overview Table 55. Ancestry Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Ancestry Rare Genetic Disease Diagnosis Solution Product Portfolio Table 57. Ancestry Recent Development Table 58. GeneDx Company Information Table 59. GeneDx Business Overview Table 60. GeneDx Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. GeneDx Rare Genetic Disease Diagnosis Solution Product Portfolio Table 62. GeneDx Recent Development Table 63. Ambry Genetics Company Information Table 64. Ambry Genetics Business Overview Table 65. Ambry Genetics Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Ambry Genetics Rare Genetic Disease Diagnosis Solution Product Portfolio Table 67. Ambry Genetics Recent Development Table 68. QIAGEN Company Information Table 69. QIAGEN Business Overview Table 70. QIAGEN Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. QIAGEN Rare Genetic Disease Diagnosis Solution Product Portfolio Table 72. QIAGEN Recent Development Table 73. Illumina Company Information Table 74. Illumina Business Overview Table 75. Illumina Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Illumina Rare Genetic Disease Diagnosis Solution Product Portfolio Table 77. Illumina Recent Development Table 78. PerkinElmer Company Information Table 79. PerkinElmer Business Overview Table 80. PerkinElmer Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. PerkinElmer Rare Genetic Disease Diagnosis Solution Product Portfolio Table 82. PerkinElmer Recent Development Table 83. Strand Life Sciences Company Information Table 84. Strand Life Sciences Business Overview Table 85. Strand Life Sciences Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Strand Life Sciences Rare Genetic Disease Diagnosis Solution Product Portfolio Table 87. Strand Life Sciences Recent Development Table 88. North America Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Rare Genetic Disease Diagnosis Solution Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2026) & (US$ Million) Table 91. North America Rare Genetic Disease Diagnosis Solution Revenue by Application (2027-2032) & (US$ Million) Table 92. North America Rare Genetic Disease Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. North America Rare Genetic Disease Diagnosis Solution Revenue by Country (2021-2026) & (US$ Million) Table 94. North America Rare Genetic Disease Diagnosis Solution Revenue by Country (US$ Million) & (2027-2032) Table 95. Europe Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Rare Genetic Disease Diagnosis Solution Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Rare Genetic Disease Diagnosis Solution Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Rare Genetic Disease Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Europe Rare Genetic Disease Diagnosis Solution Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Rare Genetic Disease Diagnosis Solution Revenue by Country (US$ Million) & (2027-2032) Table 102. China Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2026) & (US$ Million) Table 103. China Rare Genetic Disease Diagnosis Solution Revenue by Type (2027-2032) & (US$ Million) Table 104. China Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2026) & (US$ Million) Table 105. China Rare Genetic Disease Diagnosis Solution Revenue by Application (2027-2032) & (US$ Million) Table 106. Asia Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2026) & (US$ Million) Table 107. Asia Rare Genetic Disease Diagnosis Solution Revenue by Type (2027-2032) & (US$ Million) Table 108. Asia Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2026) & (US$ Million) Table 109. Asia Rare Genetic Disease Diagnosis Solution Revenue by Application (2027-2032) & (US$ Million) Table 110. Asia Rare Genetic Disease Diagnosis Solution Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Asia Rare Genetic Disease Diagnosis Solution Revenue by Region (US$ Million) & (2021-2026) Table 112. Asia Rare Genetic Disease Diagnosis Solution Revenue by Region (US$ Million) & (2027-2032) Table 113. SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2026) & (US$ Million) Table 114. SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Type (2027-2032) & (US$ Million) Table 115. SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2026) & (US$ Million) Table 116. SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Application (2027-2032) & (US$ Million) Table 117. SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Country (2021-2026) & (US$ Million) Table 119. SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Country (US$ Million) & (2027-2032) Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Rare Genetic Disease Diagnosis Solution Image Figure 2. Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rare Genetic Disease Diagnosis Solution Market Size Share 2021 VS 2025 VS 2032 Figure 4. Genetic Testing Image Figure 5. Biochemical Testing Image Figure 6. Imaging and Diagnostic Procedures Image Figure 7. Others Image Figure 8. Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Rare Genetic Disease Diagnosis Solution Market Size Share 2021 VS 2025 VS 2032 Figure 10. Clinical Genetics and Pediatric Clinic Image Figure 11. Newborn Screening Program Image Figure 12. Research and Development Image Figure 13. Others Image Figure 14. Global Rare Genetic Disease Diagnosis Solution Market Size (US$ Million) & (2021-2032) Figure 15. Global Rare Genetic Disease Diagnosis Solution Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Rare Genetic Disease Diagnosis Solution Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Rare Genetic Disease Diagnosis Solution Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Rare Genetic Disease Diagnosis Solution Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Type (2021-2032) Figure 22. Global Rare Genetic Disease Diagnosis Solution Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Application (2021-2032) Figure 25. North America Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Rare Genetic Disease Diagnosis Solution Revenue Share by Type (2021-2032) Figure 27. North America Rare Genetic Disease Diagnosis Solution Revenue Share by Application (2021-2032) Figure 28. North America Rare Genetic Disease Diagnosis Solution Revenue Share by Country (2021-2032) Figure 29. United States Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Rare Genetic Disease Diagnosis Solution Revenue Share by Type (2021-2032) Figure 34. Europe Rare Genetic Disease Diagnosis Solution Revenue Share by Application (2021-2032) Figure 35. Europe Rare Genetic Disease Diagnosis Solution Revenue Share by Country (2021-2032) Figure 36. Germany Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Rare Genetic Disease Diagnosis Solution Revenue Share by Type (2021-2032) Figure 46. China Rare Genetic Disease Diagnosis Solution Revenue Share by Application (2021-2032) Figure 47. Asia Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Rare Genetic Disease Diagnosis Solution Revenue Share by Type (2021-2032) Figure 49. Asia Rare Genetic Disease Diagnosis Solution Revenue Share by Application (2021-2032) Figure 50. Asia Rare Genetic Disease Diagnosis Solution Revenue Share by Region (2021-2032) Figure 51. Japan Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Rare Genetic Disease Diagnosis Solution Revenue Share by Type (2021-2032) Figure 59. SAMEA Rare Genetic Disease Diagnosis Solution Revenue Share by Application (2021-2032) Figure 60. SAMEA Rare Genetic Disease Diagnosis Solution Revenue Share by Country (2021-2032) Figure 61. Brazil Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Rare Genetic Disease Diagnosis Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Genetic Testing
  • Biochemical Testing
  • Imaging and Diagnostic Procedures
  • Others
Applications
  • Clinical Genetics and Pediatric Clinic
  • Newborn Screening Program
  • Research and Development
  • Others
Companies covered
  • Retrophin
  • 3billion
  • 23andMe
  • Ancestry
  • GeneDx
  • Ambry Genetics
  • QIAGEN
  • Illumina
  • PerkinElmer
  • Strand Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rare Genetic Disease Diagnosis Solution Market by Type
  3. 1.2.1 Global Rare Genetic Disease Diagnosis Solution Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Genetic Testing
  5. 1.2.3 Biochemical Testing
  6. 1.2.4 Imaging and Diagnostic Procedures
  7. 1.2.5 Others
  8. 1.3 Rare Genetic Disease Diagnosis Solution Market by Application
  9. 1.3.1 Global Rare Genetic Disease Diagnosis Solution Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Clinical Genetics and Pediatric Clinic
  11. 1.3.3 Newborn Screening Program
  12. 1.3.4 Research and Development
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Rare Genetic Disease Diagnosis Solution Market Dynamics
  1. 2.1 Rare Genetic Disease Diagnosis Solution Industry Trends
  2. 2.2 Rare Genetic Disease Diagnosis Solution Industry Drivers
  3. 2.3 Rare Genetic Disease Diagnosis Solution Industry Opportunities and Challenges
  4. 2.4 Rare Genetic Disease Diagnosis Solution Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Rare Genetic Disease Diagnosis Solution Market Perspective (2021-2032)
  2. 3.2 Global Rare Genetic Disease Diagnosis Solution Growth Trends by Region
  3. 3.2.1 Global Rare Genetic Disease Diagnosis Solution Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rare Genetic Disease Diagnosis Solution Market Size by Region (2021-2026)
  5. 3.2.3 Global Rare Genetic Disease Diagnosis Solution Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Rare Genetic Disease Diagnosis Solution Revenue by Players
  2. 4.1.1 Global Rare Genetic Disease Diagnosis Solution Revenue by Players (2021-2026)
  3. 4.1.2 Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Rare Genetic Disease Diagnosis Solution Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rare Genetic Disease Diagnosis Solution Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Rare Genetic Disease Diagnosis Solution Key Players Headquarters & Area Served
  7. 4.4 Global Rare Genetic Disease Diagnosis Solution Players, Product Type & Application
  8. 4.5 Global Rare Genetic Disease Diagnosis Solution Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Rare Genetic Disease Diagnosis Solution Market CR5 and HHI
  11. 4.6.3 2025 Rare Genetic Disease Diagnosis Solution Tier 1, Tier 2, and Tier 3
5 Rare Genetic Disease Diagnosis Solution Market Size by Type
  1. 5.1 Global Rare Genetic Disease Diagnosis Solution Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2032)
  3. 5.3 Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Type (2021-2032)
6 Rare Genetic Disease Diagnosis Solution Market Size by Application
  1. 6.1 Global Rare Genetic Disease Diagnosis Solution Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2032)
  3. 6.3 Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Retrophin
  2. 7.1.1 Retrophin Company Information
  3. 7.1.2 Retrophin Business Overview
  4. 7.1.3 Retrophin Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Retrophin Rare Genetic Disease Diagnosis Solution Product Portfolio
  6. 7.1.5 Retrophin Recent Developments
  7. 7.2 3billion
  8. 7.2.1 3billion Company Information
  9. 7.2.2 3billion Business Overview
  10. 7.2.3 3billion Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (2021-2026)
  11. 7.2.4 3billion Rare Genetic Disease Diagnosis Solution Product Portfolio
  12. 7.2.5 3billion Recent Developments
  13. 7.3 23andMe
  14. 7.3.1 23andMe Company Information
  15. 7.3.2 23andMe Business Overview
  16. 7.3.3 23andMe Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (2021-2026)
  17. 7.3.4 23andMe Rare Genetic Disease Diagnosis Solution Product Portfolio
  18. 7.3.5 23andMe Recent Developments
  19. 7.4 Ancestry
  20. 7.4.1 Ancestry Company Information
  21. 7.4.2 Ancestry Business Overview
  22. 7.4.3 Ancestry Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Ancestry Rare Genetic Disease Diagnosis Solution Product Portfolio
  24. 7.4.5 Ancestry Recent Developments
  25. 7.5 GeneDx
  26. 7.5.1 GeneDx Company Information
  27. 7.5.2 GeneDx Business Overview
  28. 7.5.3 GeneDx Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (2021-2026)
  29. 7.5.4 GeneDx Rare Genetic Disease Diagnosis Solution Product Portfolio
  30. 7.5.5 GeneDx Recent Developments
  31. 7.6 Ambry Genetics
  32. 7.6.1 Ambry Genetics Company Information
  33. 7.6.2 Ambry Genetics Business Overview
  34. 7.6.3 Ambry Genetics Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Ambry Genetics Rare Genetic Disease Diagnosis Solution Product Portfolio
  36. 7.6.5 Ambry Genetics Recent Developments
  37. 7.7 QIAGEN
  38. 7.7.1 QIAGEN Company Information
  39. 7.7.2 QIAGEN Business Overview
  40. 7.7.3 QIAGEN Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (2021-2026)
  41. 7.7.4 QIAGEN Rare Genetic Disease Diagnosis Solution Product Portfolio
  42. 7.7.5 QIAGEN Recent Developments
  43. 7.8 Illumina
  44. 7.8.1 Illumina Company Information
  45. 7.8.2 Illumina Business Overview
  46. 7.8.3 Illumina Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Illumina Rare Genetic Disease Diagnosis Solution Product Portfolio
  48. 7.8.5 Illumina Recent Developments
  49. 7.9 PerkinElmer
  50. 7.9.1 PerkinElmer Company Information
  51. 7.9.2 PerkinElmer Business Overview
  52. 7.9.3 PerkinElmer Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (2021-2026)
  53. 7.9.4 PerkinElmer Rare Genetic Disease Diagnosis Solution Product Portfolio
  54. 7.9.5 PerkinElmer Recent Developments
  55. 7.10 Strand Life Sciences
  56. 7.10.1 Strand Life Sciences Company Information
  57. 7.10.2 Strand Life Sciences Business Overview
  58. 7.10.3 Strand Life Sciences Rare Genetic Disease Diagnosis Solution Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Strand Life Sciences Rare Genetic Disease Diagnosis Solution Product Portfolio
  60. 7.10.5 Strand Life Sciences Recent Developments
8 North America
  1. 8.1 North America Rare Genetic Disease Diagnosis Solution Revenue (2021-2032)
  2. 8.2 North America Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2032)
  3. 8.2.1 North America Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2026)
  4. 8.2.2 North America Rare Genetic Disease Diagnosis Solution Revenue by Type (2027-2032)
  5. 8.3 North America Rare Genetic Disease Diagnosis Solution Revenue Share by Type (2021-2032)
  6. 8.4 North America Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2032)
  7. 8.4.1 North America Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2026)
  8. 8.4.2 North America Rare Genetic Disease Diagnosis Solution Revenue by Application (2027-2032)
  9. 8.5 North America Rare Genetic Disease Diagnosis Solution Revenue Share by Application (2021-2032)
  10. 8.6 North America Rare Genetic Disease Diagnosis Solution Revenue by Country
  11. 8.6.1 North America Rare Genetic Disease Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Rare Genetic Disease Diagnosis Solution Revenue by Country (2021-2026)
  13. 8.6.3 North America Rare Genetic Disease Diagnosis Solution Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Rare Genetic Disease Diagnosis Solution Revenue (2021-2032)
  2. 9.2 Europe Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2032)
  3. 9.2.1 Europe Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2026)
  4. 9.2.2 Europe Rare Genetic Disease Diagnosis Solution Revenue by Type (2027-2032)
  5. 9.3 Europe Rare Genetic Disease Diagnosis Solution Revenue Share by Type (2021-2032)
  6. 9.4 Europe Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2032)
  7. 9.4.1 Europe Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2026)
  8. 9.4.2 Europe Rare Genetic Disease Diagnosis Solution Revenue by Application (2027-2032)
  9. 9.5 Europe Rare Genetic Disease Diagnosis Solution Revenue Share by Application (2021-2032)
  10. 9.6 Europe Rare Genetic Disease Diagnosis Solution Revenue by Country
  11. 9.6.1 Europe Rare Genetic Disease Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Rare Genetic Disease Diagnosis Solution Revenue by Country (2021-2026)
  13. 9.6.3 Europe Rare Genetic Disease Diagnosis Solution Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Rare Genetic Disease Diagnosis Solution Revenue (2021-2032)
  2. 10.2 China Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2032)
  3. 10.2.1 China Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2026)
  4. 10.2.2 China Rare Genetic Disease Diagnosis Solution Revenue by Type (2027-2032)
  5. 10.3 China Rare Genetic Disease Diagnosis Solution Revenue Share by Type (2021-2032)
  6. 10.4 China Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2032)
  7. 10.4.1 China Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2026)
  8. 10.4.2 China Rare Genetic Disease Diagnosis Solution Revenue by Application (2027-2032)
  9. 10.5 China Rare Genetic Disease Diagnosis Solution Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rare Genetic Disease Diagnosis Solution Revenue (2021-2032)
  2. 11.2 Asia Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2032)
  3. 11.2.1 Asia Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2026)
  4. 11.2.2 Asia Rare Genetic Disease Diagnosis Solution Revenue by Type (2027-2032)
  5. 11.3 Asia Rare Genetic Disease Diagnosis Solution Revenue Share by Type (2021-2032)
  6. 11.4 Asia Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2032)
  7. 11.4.1 Asia Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2026)
  8. 11.4.2 Asia Rare Genetic Disease Diagnosis Solution Revenue by Application (2027-2032)
  9. 11.5 Asia Rare Genetic Disease Diagnosis Solution Revenue Share by Application (2021-2032)
  10. 11.6 Asia Rare Genetic Disease Diagnosis Solution Revenue by Country
  11. 11.6.1 Asia Rare Genetic Disease Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Rare Genetic Disease Diagnosis Solution Revenue by Country (2021-2026)
  13. 11.6.3 Asia Rare Genetic Disease Diagnosis Solution Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rare Genetic Disease Diagnosis Solution Revenue (2021-2032)
  2. 12.2 SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Type (2027-2032)
  5. 12.3 SAMEA Rare Genetic Disease Diagnosis Solution Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Application (2027-2032)
  9. 12.5 SAMEA Rare Genetic Disease Diagnosis Solution Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Country
  11. 12.6.1 SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Rare Genetic Disease Diagnosis Solution Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst